Vortioxetine Treatment for Depression in Alzheimer’s Disease: A Randomized, Double-blind, Placebo-controlled Study

키워드

참고문헌 (34)

1. Cumbo E, "Treatment effects of vortioxetine on cognitive functions in mild Alzheimer’disease patients with depressive symptoms : a 12 month, open-label, observational study", J Prev Alzheimers Dis, 6, pp.92~197 (2019)
2. Purandare N, "Depressive symptoms in patients with Alzheimer’s disease", Int J Geriatr Psychiatry, 16, pp.960~964 (2001)
3. Pearlson GD, "Association between family history of affective disorder and the depressive syndrome of Alzheimer’s disease", Am J Psychiatry, 147, pp.452~456 (1990)
4. Richard E, "Late-life depression, mild cognitive impairment, and dementia", JAMA Neurol, 70, pp.383~389 (2013)
5. Cannon-Spoor HE, "Effects of previous major depressive illness on cognition in Alzheimer disease patients", Am J Geriatr Psychiatry, 13, pp.312~318 (2005)
6. Lyketsos CG, "Major and minor depression in Alzheimer’s disease : prevalence and impact", J Neuropsychiatry Clin Neurosci, 9, pp.556~561 (1997)
7. Starkstein SE, "Depression in Alzheimer’s disease : phenomenology, clinical correlates and treatment", Int Rev Psychiatry, 20, pp.382~388 (2008)
8. Guan NC, "Vortioxetine for cognitive dysfunction in depression : a narrative review", Curr Top Pharmacol, 22, pp.35~44 (2018)
9. Leong C, "Antidepressants for depression in patients with dementia : a review of the literature", Consult Pharm, 29, pp.254~263 (2014)
10. Cooper C, "A systematic review of treatments for refractory depression in older people", Am J Psychiatry, 168, pp.681~688 (2011)
11. Banerjee S, "Sertraline or mirtazapine for depression in dementia(HTA-SADD) : a randomised, multicentre, double-blind, placebo-controlled trial", Lancet, 378, pp.403~411 (2011)
12. Rosenberg PB, "Sertraline for the treatment of depression in Alzheimer disease", Am J Geriatr Psychiatry, 18, pp.136~145 (2010)
13. Modrego PJ, "Depression in Alzheimer’s disease. Pathophysiology, diagnosis, and treatment", J Alzheimers Dis, 21, pp.1077~1087 (2010)
14. piperazine(Lu AA21004) : a novel multimodal compound for the treatment of major depressive disorder, "J Med Chem", 2011, 3206~3221
15. Mørk A, "Pharmacological effects of Lu AA21004 : a novel multimodal compound for the treatment of major depressive disorder", J Pharmacol Exp Ther, 340, pp.666~675 (2012)
16. Dale E, "Emerging mechanisms and treatments for depression beyond SSRIs and SNRIs", Biochem Pharmacol, 95, pp.81~97 (2015)
17. Katona C, "A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder", Int Clin Psychopharmacol, 27, pp.215~223 (2012)
18. Montgomery SA, "A randomised, double-blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or serotonin-noradrenaline reuptake inhibitor treatment switched to vortioxetine or agomelatine", Hum Psychopharmacol, 29, pp.470~482 (2014)
19. McIntyre RS, "A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults", Int J Neuropsychopharmacol, 17, pp.1557~1567 (2014)
20. McKhann G, "Clinical diagnosis of Alzheimer’s disease : report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease", Neurology, 34, pp.939~944 (1984)
21. Olin JT, "Provisional diagnostic criteria for depression of Alzheimer disease", Am J Geriatr Psychiatry, 10, pp.125~128 (2002)
22. Hughes CP, "A new clinical scale for the staging of dementia", Br J Psychiatry, 140, pp.566~572 (1982)
23. Lee JH, "Development of the Korean version of the Consortium to Establish a Registry for Alzheimer’s Disease Assessment Packet(CERAD-K) : clinical and neuropsychological assessment batteries", J Gerontol B Psychol Sci Soc Sci, 57, pp.P47~P53 (2002)
24. Folstein MF, "A practical method for grading the cognitive state of patients for the clinician", J Psychiatr Res, 12, pp.189~198 (1975)
25. Bae JN, "Development of the Korean version of the Geriatric Depression Scale and its short form among elderly psychiatric patients", J Psychosom Res, 57, pp.297~305 (2004)
26. Alexopoulos GS, "Use of the cornell scale in nondemented patients", J Am Geriatr Soc, 36, pp.230~236 (1988)
27. Borod JC, "Normative data on the boston diagnostic aphasia examination, parietal lobe battery, and the boston naming test", J Clin Neuropsychol, 2, pp.209~215 (1980)
28. Kang Y, "Current research in dementia", pp.99~107 (1998), The Korean Dementia Association
29. Wechsler D, "WMS-III: Wechsler memory scale administration and scoring manual" (1997), Psychological Corporation
30. Shah S, "Improving the sensitivity of the Barthel Index for stroke rehabilitation", J Clin Epidemiol, 42, pp.703~709 (1989)
31. Lawton MP, "Assessment of older people : self-maintaining and instrumental activities of daily living", Gerontologist, 9, pp.179~186 (1969)
32. "Package ‘multilevel’" (2016)[URL]
33. de Vasconcelos Cunha UG, "A placebo-controlled double-blind randomized study of venlafaxine in the treatment of depression in dementia", Dement Geriatr Cogn Disord, 24, pp.36~41 (2007)
34. Landes AM, "Prevalence of apathy, dysphoria, and depression in relation to dementia severity in Alzheimer’s disease", J Neuropsychiatry Clin Neurosci, 17, pp.342~349 (2005)

관련 논문AI추천